Fortrea Holdings (FTRE) Retained Earnings (2022 - 2026)

Fortrea Holdings (FTRE) reported Retained Earnings of -$195.4 million for Q1 2026, up 17.97% on a YoY basis from -$165.6 million in Q1 2025, and down 14.94% quarter-over-quarter from -$170.0 million in Q4 2025.

Fortrea Holdings (FTRE) Retained Earnings (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Retained Earnings for 5 years, with the latest figure at -$195.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Retained Earnings rose 17.97% year-over-year to -$195.4 million; the trailing twelve-month figure through Mar 2026 stood at -$195.4 million (up 17.97% YoY), and the FY2025 full-year result was -$170.0 million, up 39.91% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$195.4 million, down from -$170.0 million in the prior quarter.
  • The five-year high for Retained Earnings was -$13.1 million in Q3 2023, with the low at -$335.8 million in Q3 2024.
  • Historically, Retained Earnings has averaged -$212.0 million across 5 years, with a median of -$215.5 million in 2023.
  • Annual changes were most pronounced in 2024 — Retained Earnings sank 2463.36% — and 2025, when it soared 49.46%.
  • Fortrea Holdings' Retained Earnings stood at -$276.0 million in 2022, then increased by 21.92% to -$215.5 million in 2023, then tumbled by 31.28% to -$282.9 million in 2024, then soared by 39.91% to -$170.0 million in 2025, then fell by 14.94% to -$195.4 million in 2026.
  • The last three Retained Earnings figures came in at -$195.4 million (Q1 2026), -$170.0 million (Q4 2025), and -$170.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -153.89 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -211.85 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 130.89 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -279.00 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.88
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.59 Bn
9 Abivax 91.96 Bn 91.96 Bn - -838.07 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -195.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -195.40 Mn
Dec 31, 2025 -170.00 Mn
Sep 30, 2025 -170.40 Mn
Jun 30, 2025 -155.60 Mn
Mar 31, 2025 -238.20 Mn
Dec 31, 2024 -282.90 Mn
Sep 30, 2024 -335.80 Mn
Jun 30, 2024 -307.90 Mn
Mar 31, 2024 -169.50 Mn
Dec 31, 2023 -215.50 Mn
Sep 30, 2023 -13.10 Mn
Jun 30, 2023 -225.50 Mn
Dec 31, 2022 -276.00 Mn